Find insight on Fresnillo, the copper market, Australian mining, and more in the latest Market Talks covering Basic Materials ...

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced that Chief Executive Officer Marc Viscogliosi ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Morgan Stanley reaffirmed Tesla as its top pick, maintaining a $430 price target despite mixed analyst ratings. Some firms, ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Canaccord Genuity Group reaffirmed their buy rating on shares of Science Group (LON:SAG – Free Report) in a research note published on Monday,Digital Look reports. Canaccord Genuity Group currently ...

Canaccord Genuity analyst Tim Huff reiterated a Buy rating on Antofagasta (ANTO – Research Report) yesterday and set a price target of ...

While many of its peers abandon the lithium sector, Green Technology Metals is priming itself for development.

We recently compiled a list of the Wall Street Optimism Spills Over to These 10 Stocks on Friday. In this article, we are ...

Shares of DoubleVerify touched a record low after its full-year outlook missed Wall Street estimates, its fourth-quarter revenue came in lower than expected and two firms cut their target prices.

The general mood among these heavyweight investors is divided, with 13% leaning bullish and 72% bearish. Among these notable ...

Fintel reports that on February 28, 2025, Canaccord Genuity downgraded their outlook for ICF International (NasdaqGS:ICFI) ...